Remote Jobs at ImmuneBridge

ImmuneBridge

11 - 50 employees

💼 Consulting

🏭 Manufacturing

🧬 Biotechnology

💰 $12M Seed Round on 2023-01

Consulting • Manufacturing • Biotechnology

ImmuneBridge is developing allogeneic immunotherapies for cancer, leveraging its proprietary technology to expand cord blood-derived immune stem cells significantly. This innovative approach aims to provide a novel, scalable source of immunotherapies, particularly focusing on natural killer (NK) cells to address hematological malignancies while planning to tackle solid tumors in the future. Their platform reduces costs and accelerates discovery by using cord blood instead of iPSCs, allowing for efficient matching of HLA types and rapid iterations of therapeutic cell sources.